Spending power
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Brand profile · Biotechnology
Chugai Pharmabody Research runs a Biotechnology operation from Singapore. Publicly held, at chugai-pharmabody.com. It holds one address on record, all in Singapore. It employs 126 people, on the record. It lists antibody Drug Discovery, antibody Engineering Technology and innovative Antibody Drug among its specialties. One Singapore registration (UEN) is a confirmed match. The record links two similar brands, most of them in Biotechnology.
chugai-pharmabody.com LinkedIn
UEN201135838E
| CHUGAI PHARMABODY RESEARCH PTE. LTD. | UEN 201135838E |
|---|---|
| Confirmed matches | 1 of 1 |
A candidate is a name match on the registry, not a confirmed identity, and two candidates are ambiguity rather than a corporate structure.
In the global medical field, there are many diseases in which there are no drug or current drugs are insufficient to address the medical needs of patients. Chugai Pharmabody Research (CPR) is a subsidiary company of Chugai Pharmaceutical in Japan, a member of Roche group, and is committed to address these unmet needs by specializing in the field of antibody drug discovery utilizing proprietary antibody engineering technologies.
| Countries | 1 |
|---|---|
| Primary country | SG |
All codes: SG
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Hiring, headcount and registry-change signals, streamed to members.
Registry-filed capital and financial indicators, standardised by TheGrid.
4 employee profiles on record · names withheld.
Names and titles are intentionally absent from this page. The source relation carries no consent record across the privacy regimes this directory spans, so it is never requested and never stored. Search engines see exactly what you see here.
The people relation is never requested, so there is nothing here to unlock.
One Singapore entity on ACRA: CHUGAI PHARMABODY RESEARCH PTE. LTD. (UEN 201135838E), high confidence.
126 counted staff profiles at January 2026, inside the self-reported 51–200 band.
One address on record, Singapore only. Primary: 3 Biopolis Dr, #07 -11 to 16, Singapore 138623.
None linked to this brand.
Six tags on the brand's own list, among them Antibody Drug Discovery, Antibody Engineering Technology and Innovative Antibody Drug.
3 profiles list Chugai Pharmabody Research as a peer — 50th percentile in Biotechnology. It lists ten peers of its own.